Press release
Key Opportunities in the Market by Top Prominent - Novartis AG, Pfizer Inc., Mylan N.V. and more Forecast till 2026
Additionally, intense research and development (R&D) activities and clinical trial being conducted in nations such as the U.S and Canada are foreseen to enable growth in the global market. Besides this, the immunology biosimilars market in Europe is foreseen to witness impressive growth. Increasing adoption of biosimilars in nations such as Germany, the U.K., France, and others is likely to increase the growth rate in market.
Sample PDF Brochure https://www.fortunebusinessinsights.com/enquiry/sample/immunology-biosimilars-market-100200
Asia Pacific is anticipated to expand at a faster CAGR. Japan offers a lot of opportunity for immunology biosimilars. Owing to receiving the approval of eight biosimilars in Japan since 2016, the market is foreseen to witness growth. Furthermore, high usage of biosimilars in other application such as rheumatoid arthritis is expected to encourage the adoption of biosimilar drugs.
The report also classifies the market on the basis of disease, into arthritis, inflammatory bowel disease, and others. At present inflammatory bowel disease and arthritis together account for major portion of the market. The segments are anticipated to expand during the forecast period 2019-2026. Owing to the cost effectiveness of biosimilar they have become the preferred method to treat these diseases. This would also boost the global immunology biosimilars market.
Increasing Healthcare Expenditure to Drive the Market
Cheaper pricing of biosimilar drugs compared to biologics and increasing healthcare expenditure are some factors expected to drive the market. Moreover, expiry of patents of some biologics such as Humira, Enbrel, and others is likely to fuel the demand for biosimilar drugs.
Complex manufacturing process of biosimilars and stringent regulations for approval of biosimilar products are some key factors that may restrain the market. Moreover, slow adoption of biosimilar in developing nations is hampering the growth rate in the market.
Top Players Covered
Some of the major companies that are present in the global Immunology Biosimilars market are
• Novartis
• Pfizer
• Mylan
• AbbVie
• STADA Arzneimittel AG
• Celltrion, Inc
• KBI Biopharma, Inc.
• Amgen Inc
• and other players.
Market is Witnessing Frequent Product Launch
The immunology biosimilar of UDENYCA (pegfilgrastim-cbqv) received approval from the Food and Drug Administration in 2018. The product was developed by Coherus Biosciences and KBI Biopharma, Inc. and its reference product is Neulasta. Certain development is expected to contribute towards faster adoption of biosimilars.
Some players have adopted innovative strategies such as mergers and acquisitions to succeed in the market. Besides this, the Food and Drug Administration announced the approval for Celltrion and Teva’s rituximab biosimilar called Truxima in 2018. This is a kind of immunotherapy and has indications of treating cancer. Some of the key players operating in the global immunology biosimilars market are Novartis AG, Pfizer Inc., Mylan N.V., AbbVie Inc., STADA Arzneimittel AG, Celltrion, Inc., KBI Biopharma, Inc., and Amgen Inc.
Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/immunology-biosimilars-market-100200
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
About us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Opportunities in the Market by Top Prominent - Novartis AG, Pfizer Inc., Mylan N.V. and more Forecast till 2026 here
News-ID: 1766067 • Views: …
More Releases from Fortune Business Insights
Future of Renewable Energy Market Insights: Growth Drivers, and Regional Develop …
Global Renewable Energy Market Overview
The global renewable energy market size was valued at USD 954 billion in 2023. The market is projected to grow from USD 1,020.94 billion in 2024 to USD 1,574.17 billion by 2032, exhibiting a CAGR of 5.56% during the forecast period. Asia Pacific dominated the renewable energy market with a market share of 67.76% in 2023. The Renewable energy market in the U.S. is projected to…
DC Drives Market Overview: Opportunities, Growth Drivers, and Key Applications
Market Overview
The global DC drives market size was valued at USD 4.34 billion in 2018 and is projected to reach USD 9.23 billion by 2032, exhibiting a CAGR of 5.59% during the forecast period of 2019-2032. Asia Pacific dominated the global market with a share of 28.8% in 2018. The DC drives market in the U.S. is projected to grow significantly, reaching an estimated value of USD 1.59 billion by…
Humanoid Robots Market: An In-depth B2B Analysis of Size, Share, and Future Grow …
Brief Market Overview:
The global humanoid robots market is rapidly transitioning from a nascent field into a major growth sector, with its value escalating from USD 2.43 billion in 2023 to a projected USD 66.0 billion by 2032, demonstrating a remarkable CAGR of 45.5%.
These complex machines, which merge mechanical, electrical, and software engineering, are moving beyond research labs into real-world applications across industrial, service, and household sectors. This explosive growth…
Methanol Market Poised for Remarkable Growth, set to Reach USD 46.32 billion by …
The global methanol market size was valued at USD 31.26 billion in 2023. It is projected to grow from USD 32.70 billion in 2024 to USD 46.32 billion by 2032, exhibiting a CAGR of 4.5% during the forecast period.
The global methanol market size is set to gain traction from the urgent need to lower environmental pollution caused by the surging usage of heavy fuels, such as diesel and gasoline. Pollution…
More Releases for Novartis
Pazopanib Market Analysis By Top Keyplayers - Novartis, GlaxoSmithKline, Novarti …
The "Pazopanib Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Pazopanib Market, 2024-2031
Verified Market Research's most recent report, "Pazopanib Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the…
Onychomycosis Market to Register Incremental Growth During the Forecast Period ( …
DelveInsight's "Onychomycosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Onychomycosis, historical and forecasted epidemiology as well as the Onychomycosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Onychomycosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Onychomycosis Market Forecast
https://www.delveinsight.com/sample-request/onychomycosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Onychomycosis…
(2023-2031) Acromegaly Market | Novartis AG, Ipsen Pharma
[100 pages] Report "Acromegaly Market" detailed analysis of a business is mainly segmented by Application, by Type, Region (North America, Europe, Asia-Pacific, South America, and Middle East & Africa), manufacture and Forecast to 2031.
"Final Report will add the analysis of the impact of COVID-19 on this industry."
Global "Acromegaly Market" report analyses the best market prospects and lists the characteristics that are and will continue to propel the development of the…
Rydapt Market 2020 Clinical Analysis – Novartis
Global Rydapt Market Growth 2020-2025
The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Rydapt Market on the basis of stating current situation of the industry in 2020.
This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought…
Global HER2-negative breast cancer Treatment Market to 2025| AstraZeneca, Bristo …
Researchmoz added Most up-to-date research on "Global HER2-negative breast cancer Treatment Market Size, Status and Forecast 2019-2025" to its huge collection of research reports.
HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu or ErbB2.HER2-negative breast cancer means that the people have little or no HER2 protein.
In 2018, the global HER2-negative breast cancer Treatment…
Nilotinib Market Report 2018 – 2023: Novartis
The Study Paper in this Global Nilotinib Market includes Novartis.
Get Free Sample Brochure of Nilotinib Market spread across [142 pages] @ https://www.marketgrowthinsight.com/sample/4896
Unbiased perspective on intangible aspects such as key challenges, threats, new entrants as well as strengths and weaknesses of the prominent vendors too are…
